$AUGG
AUGUSTA GOLD CORP.

2023 Q3 Form 10-Q Financial Statement

#000121390023065721 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $780.0K $1.217M
YoY Change -50.29% -1.86%
% of Gross Profit
Research & Development $530.0K $626.4K
YoY Change -82.36% -57.72%
% of Gross Profit
Depreciation & Amortization $11.01K $11.02K
YoY Change 0.0% 0.0%
% of Gross Profit
Operating Expenses $1.350M $1.880M
YoY Change -70.7% -31.69%
Operating Profit -$1.354M -$1.880M
YoY Change -70.6% -31.69%
Interest Expense $641.3K $631.1K
YoY Change 502.52% -366.48%
% of Operating Profit
Other Income/Expense, Net $2.880M $5.338M
YoY Change -44.64% -217.02%
Pretax Income $860.0K $2.877M
YoY Change 177.72% -138.11%
Income Tax
% Of Pretax Income
Net Earnings $862.1K $2.877M
YoY Change 178.4% -138.11%
Net Earnings / Revenue
Basic Earnings Per Share $0.01 $0.03
Diluted Earnings Per Share $0.01 $0.03
COMMON SHARES
Basic Shares Outstanding 85.96M shares 85.96M shares
Diluted Shares Outstanding 85.93M shares 85.99M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.080M $2.043M
YoY Change -58.84% -59.49%
Cash & Equivalents $1.077M $2.043M
Short-Term Investments
Other Short-Term Assets $170.0K $195.9K
YoY Change 48.51% 104.72%
Inventory
Prepaid Expenses $155.8K $188.9K
Receivables
Other Receivables
Total Short-Term Assets $1.240M $2.239M
YoY Change -54.72% -56.43%
LONG-TERM ASSETS
Property, Plant & Equipment $1.055M $1.066M
YoY Change -4.01% -3.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.120M $1.116M
YoY Change
Total Long-Term Assets $61.13M $61.14M
YoY Change 2.19% 2.29%
TOTAL ASSETS
Total Short-Term Assets $1.240M $2.239M
Total Long-Term Assets $61.13M $61.14M
Total Assets $62.37M $63.38M
YoY Change -0.31% -2.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.200M $1.070M
YoY Change -61.31% -11.33%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $24.74M $24.10M
YoY Change 11.3%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $26.05M $25.28M
YoY Change 0.24% 3.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.450M $6.373M
YoY Change -64.09% -56.37%
Total Long-Term Liabilities $3.447M $6.373M
YoY Change -64.12% -56.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.05M $25.28M
Total Long-Term Liabilities $3.447M $6.373M
Total Liabilities $29.50M $31.65M
YoY Change -17.13% -18.69%
SHAREHOLDERS EQUITY
Retained Earnings -$30.71M -$31.57M
YoY Change 6.5% 8.33%
Common Stock $8.593K $8.593K
YoY Change 8.5% 8.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $32.87M $31.73M
YoY Change
Total Liabilities & Shareholders Equity $62.37M $63.38M
YoY Change -0.31% -2.36%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $862.1K $2.877M
YoY Change 178.4% -138.11%
Depreciation, Depletion And Amortization $11.01K $11.02K
YoY Change 0.0% 0.0%
Cash From Operating Activities -$970.0K -$1.547M
YoY Change -60.63% -9.56%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -970.0K -1.547M
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 0.000
Net Change In Cash -970.0K -1.547M
YoY Change -59.92% -88.93%
FREE CASH FLOW
Cash From Operating Activities -$970.0K -$1.547M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$970.0K -$1.547M
YoY Change -104.92% -114.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54653
dei Entity Registrant Name
EntityRegistrantName
AUGUSTA GOLD CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-2252162
dei Entity Address Address Line1
EntityAddressAddressLine1
Suite 555 - 999 Canada Place
dei Entity Address Address Line2
EntityAddressAddressLine2
Vancouver
dei Entity Address City Or Town
EntityAddressCityOrTown
BC
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6C 3E1
dei City Area Code
CityAreaCode
(604)
dei Local Phone Number
LocalPhoneNumber
687-1717
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
85959753 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2043276 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
332813 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
188873 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
156959 usd
CY2023Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0 usd
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
121424 usd
CY2023Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
7028 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
7028 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
2239177 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
618224 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1066420 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1088449 usd
CY2023Q2 augg Reclamation Bonds
ReclamationBonds
1115813 usd
CY2022Q4 augg Reclamation Bonds
ReclamationBonds
0 usd
CY2023Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
58962286 usd
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
58962286 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
61144519 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
60050735 usd
CY2023Q2 us-gaap Assets
Assets
63383696 usd
CY2022Q4 us-gaap Assets
Assets
60668959 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1069573 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2906285 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
24101116 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
22843322 usd
CY2023Q2 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
110700 usd
CY2022Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
1009496 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
25281389 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26759103 usd
CY2023Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
2649906 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
1804939 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
3723108 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
15615406 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
6373014 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
17420345 usd
CY2023Q2 us-gaap Liabilities
Liabilities
31654403 usd
CY2022Q4 us-gaap Liabilities
Liabilities
44179448 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85929753 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85929753 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79204606 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79204606 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
8593 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
7920 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63291549 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
56375344 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31570849 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39893753 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
31729293 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
16489511 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
63383696 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60668959 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1196164 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1219223 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2511736 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2287102 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
21000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
21000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
21000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
21000 usd
CY2023Q2 us-gaap Exploration Expense
ExplorationExpense
626426 usd
CY2022Q2 us-gaap Exploration Expense
ExplorationExpense
1481789 usd
us-gaap Exploration Expense
ExplorationExpense
1350696 usd
us-gaap Exploration Expense
ExplorationExpense
1820428 usd
CY2023Q2 us-gaap Accretion Expense
AccretionExpense
24915 usd
CY2022Q2 us-gaap Accretion Expense
AccretionExpense
18370 usd
us-gaap Accretion Expense
AccretionExpense
52822 usd
us-gaap Accretion Expense
AccretionExpense
25469 usd
CY2023Q2 us-gaap Depreciation
Depreciation
11015 usd
CY2022Q2 us-gaap Depreciation
Depreciation
11015 usd
us-gaap Depreciation
Depreciation
22029 usd
us-gaap Depreciation
Depreciation
22029 usd
CY2023Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1879520 usd
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2751397 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3958283 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4176028 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1879520 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2751397 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3958283 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4176028 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5337582 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4561381 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-13560969 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4767574 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
631079 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
1257794 usd
us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
49963 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-236815 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-21988 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-27204 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2876946 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7549593 usd
us-gaap Net Income Loss
NetIncomeLoss
8322904 usd
us-gaap Net Income Loss
NetIncomeLoss
-8970806 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85929753 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72429628 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85186643 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71479686 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85988087 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72429628 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85244977 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71479686 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
22239747 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
438522 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1421213 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
21257056 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
289338 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
471896 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
11516583 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7549593 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
25985280 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
16489511 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
472981 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
7867426 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1668671 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5445958 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
28607205 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
245142 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2876946 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
31729293 usd
us-gaap Net Income Loss
NetIncomeLoss
8322904 usd
us-gaap Net Income Loss
NetIncomeLoss
-8970806 usd
us-gaap Accretion Expense
AccretionExpense
52822 usd
us-gaap Accretion Expense
AccretionExpense
25469 usd
us-gaap Depreciation
Depreciation
22029 usd
us-gaap Depreciation
Depreciation
22029 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-13560969 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4767574 usd
us-gaap Share Based Compensation
ShareBasedCompensation
718123 usd
us-gaap Share Based Compensation
ShareBasedCompensation
910418 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
31914 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-104398 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-121424 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 usd
augg Increase Decrease Debt Issuance Costs
IncreaseDecreaseDebtIssuanceCosts
-49469 usd
augg Increase Decrease Debt Issuance Costs
IncreaseDecreaseDebtIssuanceCosts
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1836711 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
922162 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1208324 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 usd
us-gaap Increase Decrease In Asset Retirement Obligations
IncreaseDecreaseInAssetRetirementObligations
-106651 usd
us-gaap Increase Decrease In Asset Retirement Obligations
IncreaseDecreaseInAssetRetirementObligations
-49651 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5041150 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2268407 usd
augg Acquisition Of Mineral Properties
AcquisitionOfMineralProperties
0 usd
augg Acquisition Of Mineral Properties
AcquisitionOfMineralProperties
-11722039 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
838992 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12561031 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8568651 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
701225 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
augg Increase In Surety Bond Collateral
IncreaseInSuretyBondCollateral
1115813 usd
augg Increase In Surety Bond Collateral
IncreaseInSuretyBondCollateral
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
291638 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6751613 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
291638 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1710463 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14537800 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
332813 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19581707 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2043276 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5043907 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
augg Revaluation Of Asset Retirement Obligation
RevaluationOfAssetRetirementObligation
0 usd
augg Revaluation Of Asset Retirement Obligation
RevaluationOfAssetRetirementObligation
120877 usd
augg Deferred Acquistion Liability For Purchase Of Cr Reward
DeferredAcquistionLiabilityForPurchaseOfCRReward
0 usd
augg Deferred Acquistion Liability For Purchase Of Cr Reward
DeferredAcquistionLiabilityForPurchaseOfCRReward
22126000 usd
augg Incurrence Of Asset Retirement Obligation
IncurrenceOfAssetRetirementObligation
0 usd
augg Incurrence Of Asset Retirement Obligation
IncurrenceOfAssetRetirementObligation
1100434 usd
augg Purchase Of Cr Reward
PurchaseOfCRReward
0 usd
augg Purchase Of Cr Reward
PurchaseOfCRReward
11516583 usd
augg Warrant Liability From Units Placement
WarrantLiabilityFromUnitsPlacement
1668671 usd
augg Warrant Liability From Units Placement
WarrantLiabilityFromUnitsPlacement
0 usd
CY2023Q2 augg Working Capital Deficiency
WorkingCapitalDeficiency
23000000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2000000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b><span style="text-decoration:underline">Use of Estimates</span></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates have been made for share-based compensation, asset retirement obligation, warrant liability and whether acquisitions of Bullfrog Mines and CR Reward constituted an asset acquisitions or business combinations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "> </p>
CY2023Q2 augg Mineral Property Acquisition
MineralPropertyAcquisition
2814435 usd
CY2022Q2 augg Mineral Property Acquisition
MineralPropertyAcquisition
1868265 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
52822 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
25469 usd
augg Acquisition Of Cr Reward Asset Retirement And Environmental Obligations
AcquisitionOfCRRewardAssetRetirementAndEnvironmentalObligations
-38343 usd
augg Acquisition Of Cr Reward Asset Retirement And Environmental Obligations
AcquisitionOfCRRewardAssetRetirementAndEnvironmentalObligations
-130853 usd
augg Incurrence Of Asset Retirement Obligation
IncurrenceOfAssetRetirementObligation
0 usd
augg Incurrence Of Asset Retirement Obligation
IncurrenceOfAssetRetirementObligation
1100434 usd
augg Change In Estimates
ChangeInEstimates
-68308 usd
augg Change In Estimates
ChangeInEstimates
202079 usd
augg Mineral Properties Net Current
MineralPropertiesNetCurrent
110700 usd
augg Mineral Properties Net Current
MineralPropertiesNetCurrent
989300 usd
augg Mineral Properties Net Long Term
MineralPropertiesNetLongTerm
2649906 usd
augg Mineral Properties Net Long Term
MineralPropertiesNetLongTerm
2076094 usd
augg Life Of Mine
LifeOfMine
2028
augg Life Of Mine
LifeOfMine
2028
augg Discount Rate
DiscountRate
0.04 pure
augg Discount Rate
DiscountRate
0.03 pure
augg Inflation Rate
InflationRate
0.022 pure
augg Inflation Rate
InflationRate
0.026 pure
augg Cash Flows Rate
CashFlowsRate
0.04 pure
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72429628 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85186643 shares
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2876946 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7549593 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8322904 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8970806 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85929753 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71479686 shares
CY2023Q2 augg Assumed Conversion Of Dilutive Shares
AssumedConversionOfDilutiveShares
58334 shares
CY2022Q2 augg Assumed Conversion Of Dilutive Shares
AssumedConversionOfDilutiveShares
0 shares
augg Assumed Conversion Of Dilutive Shares
AssumedConversionOfDilutiveShares
58334 shares
augg Assumed Conversion Of Dilutive Shares
AssumedConversionOfDilutiveShares
0 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85988087 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72429628 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85244977 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71479686 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
39751617 shares
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12415715 usd
CY2022 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
47723766 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
60139481 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
60139481 usd
CY2021Q4 us-gaap Property Plant And Equipment Owned Gross
PropertyPlantAndEquipmentOwnedGross
44689 usd
CY2022Q4 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
44057 usd
CY2022Q4 us-gaap Property Plant And Equipment Owned Gross
PropertyPlantAndEquipmentOwnedGross
88746 usd
CY2023Q2 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
22029 usd
CY2023Q2 us-gaap Property Plant And Equipment Owned Gross
PropertyPlantAndEquipmentOwnedGross
110775 usd
CY2023Q2 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
60028706 usd
CY2020Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
9100000 shares
CY2020Q4 augg Stock Option Exercise Price Decreases
StockOptionExercisePriceDecreases
1.8
CY2020Q4 augg Royalty Percentage
RoyaltyPercentage
0.02 pure
CY2020Q4 augg Royalty Deed Description
RoyaltyDeedDescription
Pursuant to the Royalty Deed, the Barrick Royalty is reduced to the extent necessary so that royalties burdening any individual parcel or claim included in the Barrick Properties on October 26, 2020, inclusive of the Barrick Royalty, would not exceed 5.5% in the aggregate, provided that the Barrick Royalty in respect of any parcel or claim would not be less than 0.5%, even if the royalties burdening a parcel or claim included in the Barrick Properties would exceed 5.5%.
CY2022Q2 augg Initial Payment Shares Description
InitialPaymentSharesDescription
(a) $12,500,000 in cash paid at the closing; plus (b) the issuance of 7,800,000 shares of Augusta Gold common stock at closing; plus (c) $22,126,000 in cash paid on September 14, 2022 (comprising collectively the “Second Payment” and the “Deferred Payment”).
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1299 usd
CY2023Q2 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
9658 usd
CY2023Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
838992 usd
CY2023Q2 us-gaap Mineral Properties Gross
MineralPropertiesGross
46465056 usd
CY2023Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
10500 usd
CY2023Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1100434 usd
CY2023Q2 us-gaap Capitalized Costs Mineral Interests In Proved Properties
CapitalizedCostsMineralInterestsInProvedProperties
46204071 usd
CY2023Q2 augg Cash Reclamation Bonds
CashReclamationBonds
1115813 usd
augg Total Coverage Amount
TotalCoverageAmount
3188036 usd
CY2023Q1 us-gaap Partners Capital Account Units Sold In Public Offering
PartnersCapitalAccountUnitsSoldInPublicOffering
6725147 shares
CY2023Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.71
CY2023Q1 us-gaap Sale Leaseback Transaction Gross Proceeds Investing Activities
SaleLeasebackTransactionGrossProceedsInvestingActivities
11500000 cad
CY2023Q1 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
3362573 shares
us-gaap Deferred Compensation Arrangement With Individual Cash Awards Granted Percentage
DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage
0.05 pure
us-gaap Stock Dividends Shares
StockDividendsShares
336257 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.71
CY2011Q3 augg Shareholder In Percentage
ShareholderInPercentage
0.0499 pure
CY2011Q3 augg Prior Notice In Percentage
PriorNoticeInPercentage
0.0999 pure
CY2012Q4 augg Public Conversion Percentage
PublicConversionPercentage
0.0499 pure
CY2022Q2 augg Outstanding Shares
OutstandingShares
677084 shares
CY2021Q1 augg Common Stock Percenatage
CommonStockPercenatage
0.10 pure
CY2022Q2 us-gaap Additional Collateral Aggregate Fair Value
AdditionalCollateralAggregateFairValue
324816 usd
CY2022Q3 us-gaap Additional Collateral Aggregate Fair Value
AdditionalCollateralAggregateFairValue
99021 usd
CY2022Q3 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
2
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
4541667 shares
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
480250 usd
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
188233 usd
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
292017 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
718123 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
910418 usd
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
4800002 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.55
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M9D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
29817 usd
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022 augg Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercise Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExerciseWeightedAverageRemainingContractualTerm2
P0Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 usd
CY2022 augg Stock Issued During Period Shares Stock Options Issued
StockIssuedDuringPeriodSharesStockOptionsIssued
450000 shares
CY2022 augg Share Based Compensation Arrangements By Share Based Payment Award Options Issued In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice
2.03
CY2022 augg Sharebased Compensation Arrangement By Sharebased Payment Award Options Issued Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuedWeightedAverageRemainingContractualTerm2
P5Y
CY2022 augg Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Issued Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIssuedDateIntrinsicValue
0 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
50000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2
CY2022 augg Sharebased Compensation Arrangement By Sharebased Payment Award Options Canceled Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsCanceledWeightedAverageRemainingContractualTerm2
P0Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
0
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
5200002 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.56
CY2022 augg Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm
P3Y5M12D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
57468 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
augg Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercise Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExerciseWeightedAverageRemainingContractualTerm2
P0Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 usd
augg Stock Issued During Period Shares Stock Options Issued
StockIssuedDuringPeriodSharesStockOptionsIssued
0 shares
augg Share Based Compensation Arrangements By Share Based Payment Award Options Issued In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice
0
augg Sharebased Compensation Arrangement By Sharebased Payment Award Options Issued Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuedWeightedAverageRemainingContractualTerm2
P0Y
augg Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Issued Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIssuedDateIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
150000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.53
augg Sharebased Compensation Arrangement By Sharebased Payment Award Options Canceled Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsCanceledWeightedAverageRemainingContractualTerm2
P0Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
0
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
5050002 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.48
augg Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm
P2Y11M4D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8400 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3658335 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.47
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P2Y10M17D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
8400 usd
us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
34701615 shares
CY2021 augg Warrants Issuedincludes Expired Warrants
WarrantsIssuedincludesExpiredWarrants
36344471 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
31427195 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
208334 shares
CY2022 augg Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrumentswarrantsissued
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentswarrantsissued
0 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
216076 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
31002785 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
augg Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrumentswarrantsissued
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentswarrantsissued
3698830 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
0 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
34701615 shares
augg Relatedpartyoffice
Relatedpartyoffice
52182 usd
CY2020Q4 augg Fair Market Value Of Common Stock
FairMarketValueOfCommonStock
1.26
CY2022Q4 augg Fair Market Value Of Common Stock
FairMarketValueOfCommonStock
1.4
augg Fair Market Value Of Common Stock
FairMarketValueOfCommonStock
0.75
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.38
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.33
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.36
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y3M18D
CY2020Q4 augg Financial Instruments Volatility Range
FinancialInstrumentsVolatilityRange
0.684 pure
CY2022Q4 augg Financial Instruments Volatility Range
FinancialInstrumentsVolatilityRange
1.015 pure
augg Financial Instruments Volatility Range
FinancialInstrumentsVolatilityRange
0.846 pure
CY2020Q4 augg Financila Instruments Riskfree Rate
FinancilaInstrumentsRiskfreeRate
0.0018 pure
CY2022Q4 augg Financila Instruments Riskfree Rate
FinancilaInstrumentsRiskfreeRate
0.0441 pure
augg Financila Instruments Riskfree Rate
FinancilaInstrumentsRiskfreeRate
0.054 pure
augg Warrant Liability
WarrantLiability
41536 usd
CY2022Q3 us-gaap Other Investments
OtherInvestments
22232561 usd
CY2023Q2 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.03 pure
us-gaap Property Management Fee Percent Fee
PropertyManagementFeePercentFee
0.005 pure
us-gaap Principal Transactions Revenue
PrincipalTransactionsRevenue
22232561 usd
CY2023Q2 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
3152 usd
CY2023Q2 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1865403 usd
CY2023Q2 us-gaap Loans Payable
LoansPayable
24101116 usd
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
228542 usd
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
221418 usd
augg Relatedpartyoffice
Relatedpartyoffice
35278 usd
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
51523 usd
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
7920 usd
augg Total Related Party Costs1
TotalRelatedPartyCosts1
332247 usd
augg Total Related Party Costs1
TotalRelatedPartyCosts1
299340 usd
us-gaap Payments For Rent
PaymentsForRent
183000 usd
CY2023Q2 augg Operating Leases Future Minimum Payment Due In Two Years
OperatingLeasesFutureMinimumPaymentDueInTwoYears
95557 usd
CY2023Q2 augg Operating Leases Future Minimum Payment Due In Three Years
OperatingLeasesFutureMinimumPaymentDueInThreeYears
87594 usd
CY2023Q2 augg Operating Leases Future Minimum Payment Due
OperatingLeasesFutureMinimumPaymentDue
183151 usd
augg Share Based Payments Expense To Related Parties
ShareBasedPaymentsExpenseToRelatedParties
718123 usd
augg Share Based Payments Expense To Related Parties
ShareBasedPaymentsExpenseToRelatedParties
910418 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
39900 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
22400 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2400 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2400 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2400 usd
CY2023Q2 augg Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
2400 usd
CY2023Q2 augg Lessee Operating Lease Liability Payments Due Year Seven
LesseeOperatingLeaseLiabilityPaymentsDueYearSeven
2400 usd
CY2023Q2 augg Lessee Operating Lease Liability Payments Due Year Eight
LesseeOperatingLeaseLiabilityPaymentsDueYearEight
2400 usd
CY2017Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P30Y
CY2017Q3 augg Number Of Patented Mining
NumberOfPatentedMining
24 pure
CY2017Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
1 pure
CY2023Q2 us-gaap Other Commitment
OtherCommitment
50000 usd
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
500000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
132000 usd
augg Leases Future Minimum Payments Due In Four Years
LeasesFutureMinimumPaymentsDueInFourYears
21000 usd
augg Leases Future Minimum Payments Due In Five Years
LeasesFutureMinimumPaymentsDueInFiveYears
25000 usd
augg Leases Future Minimum Payments Due In Five Years One
LeasesFutureMinimumPaymentsDueInFiveYearsOne
30000 usd
augg Leases Future Minimum Payments Due In Five Years Two
LeasesFutureMinimumPaymentsDueInFiveYearsTwo
40000 usd
augg Leases Future Minimum Payments Due In Five Years Three
LeasesFutureMinimumPaymentsDueInFiveYearsThree
45000 usd
CY2023Q4 augg Purchase Rights
PurchaseRights
1 pure
CY2023Q4 us-gaap Area Of Land
AreaOfLand
156 sqm
us-gaap Public Utilities Property Plant And Equipment Interest Rate On Intermediary Debt For Electric Utility Plant Construction
PublicUtilitiesPropertyPlantAndEquipmentInterestRateOnIntermediaryDebtForElectricUtilityPlantConstruction
1 pure
CY2022 us-gaap Repayments Of Debt
RepaymentsOfDebt
160000 usd
augg Remaining Payment
RemainingPayment
30000 usd
CY2020Q4 augg Option Agreement Description
OptionAgreementDescription
Bullfrog Mines entered into a mining option agreement with Abitibi Royalties (USA) Inc. (“Abitibi”) granting Bullfrog Mines the option (the “Abitibi Option”) to acquire forty-three unpatented lode mining claims to the south of the Bullfrog deposit. The Abitibi Option was amended on December 9, 2022, to extend the exercise deadline and to increase the last payment amount required to exercise the option. Bullfrog Mines made an initial payment to Abitibi of C$25,000 and exercised the Abitibi Option in full on January 30, 2023, by:   ● Paying to Abitibi C$50,000 in cash before December 9, 2021;   ● Paying to Abitibi C$78,750 in cash before January 30, 2023; and   ● Granting to Abitibi a 2% net smelter royalty on the claims subject to the Abitibi Option on January 30, 2023, of which Bullfrog Mines has the option to purchase 0.5% for C$500,000 on or before December 9, 2030.
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001448597

Files In Submission

Name View Source Status
0001213900-23-065721-index-headers.html Edgar Link pending
0001213900-23-065721-index.html Edgar Link pending
0001213900-23-065721.txt Edgar Link pending
0001213900-23-065721-xbrl.zip Edgar Link pending
augg-20230630.xsd Edgar Link pending
f10q0623ex31-1_augusta.htm Edgar Link pending
f10q0623ex31-2_augusta.htm Edgar Link pending
f10q0623ex32-1_augusta.htm Edgar Link pending
f10q0623ex32-2_augusta.htm Edgar Link pending
f10q0623_augustagold.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
augg-20230630_cal.xml Edgar Link unprocessable
augg-20230630_def.xml Edgar Link unprocessable
augg-20230630_lab.xml Edgar Link unprocessable
augg-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10q0623_augustagold_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending